Delcath Systems, Inc.
DCTH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000872912
No open-market purchases or sales by Delcath Systems, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 119
- 13F valueReported value at the end of Q2 2026
- $219.2M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DCTH, Q2 2026
No superinvestor reported holding DCTH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Delcath Systems, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 6 | Same day | Pennell SandraChief Financial Officer | PPurchase | +5.53K | $9.04 | +$50.0K | +7.7%77.0K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Michel Gerard JCHIEF EXECUTIVE OFFICER | PPurchase | +11.2K | $8.96 | +$100.4K | +3.4%342.0K after | |
| Nov 25, 2025 (view filing) | Nov 21 | 4 days | Sylvester John RichardDirector | PPurchase | +4.39K | $8.89 | +$39.0K | +41.6%14.9K after | |
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | Michel Gerard JCHIEF EXECUTIVE OFFICER | PPurchase | +11.5K | $8.53 | +$98.1K | +3.6%330.8K after | |
| Mar 20, 2024 (view filing)7:07 PM ET | Mar 19 | 1 day | Rosalind Advisors, Inc. and 2 othersDirector | PPurchaseDelcath Systems, Inc. Common Shares | +619.9K | $3.71 | +$2.30M | –836.1K after | Derivative |
| Mar 20, 2024 (view filing) | Mar 19 | 1 day | Aharon GilDirector | PPurchase | +26.9K | $3.72 | +$100.0K | +2.6%1.07M after | |
| Mar 20, 2024 (view filing) | Mar 19 | 1 day | Salamon Steven A JDirector | PPurchase | +26.9K | $3.72 | +$100.0K | +2.5%1.12M after | |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Vukovic VojoChief Medical Officer | PPurchase | +40.0K | $3.00 | +$120.0K | +66.7%100.0K after | |
| Dec 11, 2023 (view filing) | Dec 8 | 3 days | Michel Gerard JChief Executive Officer | PPurchase | +34.0K | $2.94 | +$100.0K | +14.9%262.3K after | |
| Nov 21, 2023 (view filing)11:07 AM ET | Nov 17 | 4 days | Rosalind Advisors, Inc. and 2 othersDirector | PPurchase | +100.0K | $2.40 | +$240.4K | +10.7%1.04M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Delcath Systems, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3,300,389 | $41.6M | 15.61% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,706,802 | $34.1M | 0.00% | +922,336+51.7% | Added |
| Vanguard Capital Management LLC | 1,221,247 | $15.4M | 0.00% | −108,041−8.1% | Reduced |
| Propel Bio Management, LLC | 871,460 | $11.0M | 5.74% | −108,238−11.0% | Reduced |
| Geode Capital Management, LLC | 733,115 | $9.23M | 0.00% | +41,084+5.9% | Added |
| State Street Corp | 679,280 | $8.55M | 0.00% | +14,852+2.2% | Added |
| Algert Global LLC | 580,708 | $7.31M | 0.09% | +434,975+298.5% | Added |
| Millennium Management LLC | 566,371 | $7.13M | 0.00% | −21,684−3.7% | Reduced |
| Divisadero Street Capital Management, LP | 499,796 | $6.29M | 0.15% | 00.0% | Unchanged |
| Morgan Stanley | 407,983 | $5.14M | 0.00% | +22,459+5.8% | Added |